Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 안정자 | * |
dc.contributor.author | 우복희 | * |
dc.contributor.author | 김승철 | * |
dc.contributor.author | 문혜성 | * |
dc.date.accessioned | 2016-08-28T11:08:26Z | - |
dc.date.available | 2016-08-28T11:08:26Z | - |
dc.date.issued | 2000 | * |
dc.identifier.issn | 1048-891X | * |
dc.identifier.other | OAK-440 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/218640 | - |
dc.description.abstract | The aim of this study was to determine the value of the measurement of serum VEGF and TGF-β1 levels in the diagnosis of cervical cancer and to see whether these levels decrease after treatment for cervical cancer. We measured serum VEGF and TGF-β1 levels through EIA in patients with CIN (n = 35), and cervical squamous cell cancer (n = 48). We also measured serum VEGF, TGF-β1, and SCC antigen levels before and after radiotherapy in 13 cervical squamous cell cancer patients. The sizes of the tumors in those patients were measured by a computer tomography scan or magnetic resonance imaging. The serum VEGF levels were different between CIN and cervical cancer groups (p < 0.1), and the serum TGF-β 1 levels in the cervical cancer group were lower than those in the other groups (P < 0.05). The serum VEGF levels were significantly related to the serum TGF-β 1 levels in the cervical cancer patients (P < 0.01). In the cervical cancer patients, the decrease in the circulating VEGF levels after receiving radiotherapy was related to the decrease in tumor size (P < 0.01). While the measurement of serum VEGF level is adjuvant in diagnosing cervical cancers, serial serum VEGF level measurements may find a clinical use in the follow-up of women treated for cervical cancer. | * |
dc.language | English | * |
dc.title | Concentration of vascular endothelial growth factor (VEGF) and transforming growth factor β-1 (TGF-β1) in the serum of patients with cervical cancer: Prediction of response | * |
dc.type | Article | * |
dc.relation.issue | 2 | * |
dc.relation.volume | 10 | * |
dc.relation.index | SCI | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 151 | * |
dc.relation.lastpage | 156 | * |
dc.relation.journaltitle | International Journal of Gynecological Cancer | * |
dc.identifier.doi | 10.1046/j.1525-1438.2000.00013.x | * |
dc.identifier.wosid | WOS:000087345600010 | * |
dc.identifier.scopusid | 2-s2.0-0034116456 | * |
dc.author.google | Moon H.-S. | * |
dc.author.google | Kim S.C. | * |
dc.author.google | Ahn J.J. | * |
dc.author.google | Woo B.H. | * |
dc.contributor.scopusid | 안정자(7403019711) | * |
dc.contributor.scopusid | 우복희(7004853990;36939080900) | * |
dc.contributor.scopusid | 김승철(35264000100) | * |
dc.contributor.scopusid | 문혜성(14319143700) | * |
dc.date.modifydate | 20240423081003 | * |